Teleflex Incorporated (NYSE:TFX) Shares Sold by Kentucky Retirement Systems Insurance Trust Fund

Kentucky Retirement Systems Insurance Trust Fund trimmed its holdings in shares of Teleflex Incorporated (NYSE:TFXFree Report) by 7.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,551 shares of the medical technology company’s stock after selling 123 shares during the period. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Teleflex were worth $351,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Schechter Investment Advisors LLC purchased a new stake in Teleflex during the fourth quarter worth $222,000. Pallas Capital Advisors LLC purchased a new stake in Teleflex during the fourth quarter worth $994,000. Bridge Creek Capital Management LLC raised its position in Teleflex by 1.8% during the fourth quarter. Bridge Creek Capital Management LLC now owns 15,833 shares of the medical technology company’s stock worth $3,948,000 after acquiring an additional 283 shares during the period. Oak Thistle LLC acquired a new position in Teleflex during the fourth quarter worth $386,000. Finally, Venturi Wealth Management LLC raised its position in Teleflex by 33.3% during the fourth quarter. Venturi Wealth Management LLC now owns 184 shares of the medical technology company’s stock worth $46,000 after acquiring an additional 46 shares during the period. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Trading Up 0.9 %

Teleflex stock traded up $2.05 during midday trading on Monday, hitting $222.35. 80,408 shares of the stock were exchanged, compared to its average volume of 364,704. Teleflex Incorporated has a fifty-two week low of $177.63 and a fifty-two week high of $257.85. The stock has a market capitalization of $10.47 billion, a price-to-earnings ratio of 35.36, a PEG ratio of 2.13 and a beta of 1.13. The stock’s 50-day simple moving average is $212.42 and its 200 day simple moving average is $221.81. The company has a current ratio of 2.51, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFXGet Free Report) last released its quarterly earnings data on Thursday, May 2nd. The medical technology company reported $3.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.07 by $0.14. Teleflex had a net margin of 9.82% and a return on equity of 14.78%. The firm had revenue of $737.80 million during the quarter, compared to analysts’ expectations of $726.85 million. During the same period last year, the business earned $3.09 earnings per share. Teleflex’s revenue was up 3.8% compared to the same quarter last year. On average, equities analysts anticipate that Teleflex Incorporated will post 13.75 EPS for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, June 14th. Shareholders of record on Wednesday, May 15th were paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.61%. The ex-dividend date of this dividend was Tuesday, May 14th. Teleflex’s dividend payout ratio (DPR) is presently 21.83%.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the stock. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Friday, May 3rd. Piper Sandler upgraded shares of Teleflex from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $205.00 to $245.00 in a research report on Monday, July 1st. Finally, Truist Financial increased their target price on shares of Teleflex from $235.00 to $240.00 and gave the company a “hold” rating in a research report on Tuesday, July 16th. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, Teleflex presently has a consensus rating of “Moderate Buy” and a consensus price target of $263.14.

View Our Latest Research Report on Teleflex

Teleflex Company Profile

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Featured Articles

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFXFree Report).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.